Treatment for intracerebral hemorrhage: Dawn of a new era

医学 随机对照试验 脑出血 重症监护医学 冲程(发动机) 血肿 格拉斯哥昏迷指数 外科 机械工程 工程类
作者
David Seiffge,Craig S. Anderson
出处
期刊:International Journal of Stroke [SAGE]
卷期号:19 (5): 482-489 被引量:2
标识
DOI:10.1177/17474930241250259
摘要

Intracerebral hemorrhage (ICH) is a devastating disease, causing high rates of death, disability, and suffering across the world. For decades, its treatment has been shrouded by the lack of reliable evidence, and consequently, the presumption that an effective treatment is unlikely to be found. Neutral results arising from several major randomized controlled trials had established a negative spirit within and outside the stroke community. Frustration among researchers and a sense of nihilism in clinicians has created the general perception that patients presenting with ICH have a poor prognosis irrespective of them receiving any form of active management. All this changed in 2023 with the positive results on the primary outcome in randomized controlled trials showing treatment benefits for a hyperacute care bundle approach (INTERACT3), early minimal invasive hematoma evacuation (ENRICH), and use of factor Xa-inhibitor anticoagulation reversal with andexanet alfa (ANNEXa-I). These advances have now been extended in 2024 by confirmation that intensive blood pressure lowering initiated within the first few hours of the onset of symptoms can substantially improve outcome in ICH (INTERACT4) and that decompressive hemicraniectomy is a viable treatment strategy in patients with large deep ICH (SWITCH). This evidence will spearhead a change in the perception of ICH, to revolutionize the care of these patients to ultimately improve their outcomes. We review these and other recent developments in the hyperacute management of ICH. We summarize the results of randomized controlled trials and discuss related original research papers published in this issue of the International Journal of Stroke. These exciting advances demonstrate how we are now at the dawn of a new, exciting, and brighter era of ICH management.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
zy发布了新的文献求助10
2秒前
唯馨馨发布了新的文献求助10
2秒前
lyl19880908应助科研通管家采纳,获得10
2秒前
完美世界应助科研通管家采纳,获得10
3秒前
斯文败类应助科研通管家采纳,获得10
3秒前
wanci应助科研通管家采纳,获得10
3秒前
含蓄的妙旋完成签到,获得积分10
3秒前
科研通AI2S应助科研通管家采纳,获得10
3秒前
丘比特应助科研通管家采纳,获得10
3秒前
在水一方应助科研通管家采纳,获得10
3秒前
今后应助科研通管家采纳,获得10
4秒前
orixero应助科研通管家采纳,获得10
4秒前
科研通AI2S应助科研通管家采纳,获得10
4秒前
小蘑菇应助科研通管家采纳,获得10
4秒前
4秒前
双丁宝贝应助科研通管家采纳,获得10
4秒前
4秒前
4秒前
5秒前
科目三应助科研通管家采纳,获得10
5秒前
风中烧鹅发布了新的文献求助10
6秒前
zy完成签到,获得积分10
7秒前
bibo完成签到,获得积分10
7秒前
7秒前
华仔应助精明白风采纳,获得10
8秒前
俏皮问晴发布了新的文献求助10
10秒前
赘婿应助清脆的书桃采纳,获得10
10秒前
简单的梦槐完成签到,获得积分10
10秒前
stuffmatter应助樱子采纳,获得10
12秒前
打打应助活力的泥猴桃采纳,获得10
12秒前
慕青应助活力的泥猴桃采纳,获得10
12秒前
所所应助Harssi采纳,获得10
13秒前
无花果应助Harssi采纳,获得10
13秒前
谦让盼海完成签到,获得积分10
13秒前
多啦啦完成签到,获得积分10
13秒前
英俊的铭应助张立人采纳,获得10
14秒前
Jasper应助看山采纳,获得10
14秒前
14秒前
熠迩完成签到,获得积分10
15秒前
高分求助中
中国国际图书贸易总公司40周年纪念文集 大事记1949-1987 2000
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
草地生态学 880
Threaded Harmony: A Sustainable Approach to Fashion 799
Basic Modern Theory of Linear Complex Analytic 𝑞-Difference Equations 500
Queer Politics in Times of New Authoritarianisms: Popular Culture in South Asia 500
Livre et militantisme : La Cité éditeur 1958-1967 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3058279
求助须知:如何正确求助?哪些是违规求助? 2714388
关于积分的说明 7440415
捐赠科研通 2359676
什么是DOI,文献DOI怎么找? 1250252
科研通“疑难数据库(出版商)”最低求助积分说明 607401
版权声明 596410